DiagnoSearch
Mumbai, India· Est.
India‑based CRO delivering comprehensive, data‑driven clinical trial services across all phases and therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based CRO delivering comprehensive, data‑driven clinical trial services across all phases and therapeutic areas.
OncologyImmunologyCardiologyNeurologyMetabolismRespiratoryGastroenterologyNephrologyOphthalmology
Technology Platform
A proprietary digital ecosystem integrating IWRS, EDC, and advanced analytics dashboards, supported by a central laboratory and over 270 SOPs to enable end‑to‑end trial execution and real‑time monitoring.
Opportunities
Expansion into decentralized trial designs and AI‑enhanced data analytics can drive new revenue streams, while growing demand for CRO services in emerging markets offers geographic growth.
Risk Factors
Intense competition from larger global CROs and evolving regulatory requirements in diverse jurisdictions could pressure margins and operational complexity.
Competitive Landscape
DiagnoSearch competes with multinational CROs such as IQVIA and PPD, differentiating itself through a strong regional presence, cost‑effective pricing, and a unified digital platform that streamlines multi‑country studies.